|
A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies |
|
|
|
Titel: |
A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies |
Auteur: |
Kwiatek, Michal Murthy, Guru Subramanian Guru Hoffmann, Marc Tessoulin, Benoit Danilov, Alexey Alencar, Alvaro J. Shah, Nirav N. Ghesquieres, Hervé Le Gouill, Steven Jurczak, Wojciech Han, Hongmei Yuen, Eunice Patel, Vishalkumar Guo-Avrutin, Yingying Pauff, James M. Roeker, Lindsey E. |
Verschenen in: |
Clinical lymphoma myeloma and leukemia |
Paginering: |
Jaargang 25 () nr. 7 pagina's 512-519 |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|